samedan logo
 
 
spacer
home > pmps > winter 2021 > spotlight - dupont - dosage forms and release technologies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Spotlight - DuPont - Dosage Forms and Release Technologies

PMPS: METHOCEL™ DC2 HPMC offers fewer production steps and less waste, how can this, and similar new technologies, help the industry from drug creation to delivery?

Rina Chokshi: The main advantages of METHOCEL™ DC2 HPMC are its ease of use and simplified application during direct compression manufacturing (1). It improves content uniformity of the final dosage form, resulting in lower cost of production and more consistent product performance for patients.

METHOCEL™ DC2 HPMC also has implications for those wishing to adopt continuous manufacturing. Its improved flow properties are essential to maintaining performance and high throughput. METHOCEL™ DC2 HPMC’s particle morphology is specifically designed to offer better flow, as the particles are less fibrous, more spherical, and homogenous in shape and physical properties. Because of this, manufacturers can avoid more expensive and complex granulation processes.

Our Alubra® sodium stearyl fumarate boasts benefits for continuous manufacturing, too (2). It helps manufacturers achieve desired tablet hardness, while avoiding over-lubrication since it can be integrated earlier in the process than alternative products, thus circumventing lubrication issues.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rina Chokshi, Global Commercial Manager at DuPont Pharma Solutions
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration

Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with promising advantages that nasal route could offer, Nemera is thrilled to extend its portfolio by launching its unidose system, UniSpray, for systemic-acting drug administration to face emergency and crisis.
More info >>

White Papers

ECCRT

ECCRT

The European Centre for Clinical Research Training (ECCRT) is a professional clinical research training provider focusing on the transfer of implementable knowledge for the day-to-day activities of our participants whether being new to the industry, starters on the job, or seasoned professionals. Our mission is to facilitate Clinical Research professionals to excel in their job for the benefit of patients. We aim to achieve this by providing clinical research professionals with competencies to develop new therapies for patients quicker & more efficiently, without jeopardizing quality and safety.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement